A 'stepdown' approach to reduce doses of inhaled steroids in patients with chronic asthma can cut the risk of side effects without compromising asthma control, say researchers in this week's BMJ.

A new study undertaken by the Medical Research Institute of New Zealand (MRINZ) shows that adults with asthma can safely simplify their treatment, reduce overall steroid exposure and improve asthma ...

With new guidelines for the treatment of moderate to severe asthma, experts noted a shift toward increasing caution in ...

Taking oral or inhaled glucocorticoids, a type of steroid used to curb inflammation in asthma and other autoimmune disorders, may be linked to damaging changes in the white matter of the brain, a new ...

While inhalers and nasal sprays with corticosteroids are often prescribed for asthma and allergies, experts warn that ...

ORLANDO — Clinicians commonly recommend that the dose of inhaled glucocorticoids be quintupled when patients start losing control of their asthma, but this strategy fails to prevent exacerbations in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers captured how caregivers view oral ...

Please provide your email address to receive an email when new articles are posted on . With $31 million in funding from the Patient-Centered Outcomes Research Institute, researchers will investigate ...

Long-term use of inhalers and nasal sprays, common for respiratory issues, may increase infection risks, a meta-analysis reveals. Researchers found li ...

A phase 4 study found severe asthma can be controlled using biologic therapies, without the addition of high-dose inhaled steroids. Among a cohort of patients with severe asthma using the biologic ...

Asthma is an umbrella diagnosis covering a number of heterogeneous inflammatory pathways. In the past, excessive T-helper cell type 2 (Th2) response and immunoglobulin E (IgE) sensitivity were thought ...